NFP
MRK icon

NorthLanding Financial Partners’s Merck MRK Stock Holding History

NorthLanding Financial Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,759
Closed -$294K – 50
2023
Q1 		$294K Sell
2,759
-1,427
-34% -$154K 0.21% 54
2022
Q4 		$464K Sell
4,186
-2,735
-40% -$280K 0.33% 43
2022
Q3 		$596K Buy
+6,921
New +$618K 0.47% 34

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NorthLanding Financial Partners's MRK Position: Q2 2023 in Review

NorthLanding Financial Partners sold out of Merck (MRK) in Q2 2023, closing a stake of 2,759 shares — an estimated $294K sold.

NorthLanding Financial Partners first reported a position in MRK in Q3 2022 and held it in 3 quarters. The position peaked at $596K in Q3 2022. 3,256 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

  • NorthLanding Financial Partners reported no remaining Merck position as of Q2 2023 after selling out during the quarter.
  • NorthLanding Financial Partners sold 2,759 Merck shares in Q2 2023, an estimated $294K.
  • NorthLanding Financial Partners first reported a position in Merck in Q3 2022 and held it in 3 quarters.
  • NorthLanding Financial Partners's Merck position peaked at $596K in Q3 2022.
  • 3,256 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on NorthLanding Financial Partners's 13F filing for Q2 2023, filed 8 Aug 2023.